ONC – BeOne Medicines Ltd ADR

ONC — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

1.09

Margin Of Safety %

-9

Put/Call OI Ratio

1.15

EPS Next Q Diff

-0.29

EPS Last/This Y

-1.94

EPS This/Next Y

2.92

Price

314.61

Target Price

413.14

Analyst Recom

1.23

Performance Q

-10.85

Upside

-50.2%

Beta

0.51

Ticker: ONC

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-13	ONC	305.21	1.45	0.58	3381
2026-04-14	ONC	309.81	1.44	0.60	3388
2026-04-15	ONC	320.08	1.44	0.26	3395
2026-04-16	ONC	320.82	1.43	4.05	3406
2026-04-17	ONC	323.32	1.42	1.77	3429
2026-04-20	ONC	318.26	1.37	0.46	3036
2026-04-21	ONC	312.27	1.37	10.00	3047
2026-04-22	ONC	312.26	1.37	1.24	3057
2026-04-23	ONC	299.55	1.35	10.35	3382
2026-04-24	ONC	300.76	1.46	0.50	3604
2026-04-27	ONC	298.92	1.46	0.25	3605
2026-04-28	ONC	297.92	1.45	1.25	3611
2026-04-29	ONC	290.61	1.44	0.33	3614
2026-04-30	ONC	295.31	1.24	0.00	3340
2026-05-01	ONC	293.43	1.23	999.99	2877
2026-05-04	ONC	297.15	1.23	0.60	2878
2026-05-05	ONC	297.38	1.23	0.02	2880
2026-05-06	ONC	313.24	1.24	0.31	2865
2026-05-07	ONC	317.24	1.23	0.27	2883
2026-05-08	ONC	311.96	1.23	0.62	2883
2026-05-11	ONC	310.58	1.18	0.05	2866
2026-05-12	ONC	314.82	1.15	1.60	2820
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-13	ONC	305.37	8351.1	310.9	5.52
2026-04-14	ONC	309.54	8351.1	331.9	5.52
2026-04-15	ONC	320.05	8351.1	371.5	5.52
2026-04-16	ONC	321.25	8351.1	345.5	5.52
2026-04-17	ONC	324.46	8351.1	304.3	5.52
2026-04-20	ONC	318.68	8351.1	304.8	5.52
2026-04-21	ONC	314.67	8351.1	304.0	5.52
2026-04-22	ONC	312.00	8351.1	304.6	5.52
2026-04-23	ONC	299.89	8351.1	282.6	5.52
2026-04-24	ONC	300.53	8351.1	299.1	5.61
2026-04-27	ONC	299.77	8595.0	307.3	5.73
2026-04-28	ONC	298.57	8595.0	307.5	5.73
2026-04-29	ONC	290.90	8595.0	295.5	5.73
2026-04-30	ONC	296.88	7957.5	310.5	5.67
2026-05-01	ONC	294.02	7957.5	327.4	5.67
2026-05-04	ONC	297.19	7957.5	337.0	5.67
2026-05-05	ONC	296.65	7957.5	321.1	5.67
2026-05-06	ONC	311.78	7957.5	367.8	5.67
2026-05-07	ONC	316.66	7957.5	408.6	5.67
2026-05-08	ONC	312.76	53.7	40.4	5.67
2026-05-11	ONC	310.28	53.7	68.8	5.67
2026-05-12	ONC	314.61	84.4	74.7	6.12
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-13	ONC	-19.97	0.90	1.20
2026-04-14	ONC	-19.97	0.90	1.20
2026-04-15	ONC	-19.97	0.90	1.20
2026-04-17	ONC	-19.97	0.90	1.20
2026-04-20	ONC	-19.97	1.00	1.20
2026-04-21	ONC	-19.97	1.00	1.20
2026-04-22	ONC	-19.97	1.00	1.20
2026-04-23	ONC	-18.77	1.00	1.20
2026-04-24	ONC	-18.77	1.00	1.20
2026-04-27	ONC	-18.77	0.91	1.14
2026-04-28	ONC	-18.77	0.91	1.14
2026-04-29	ONC	-18.77	0.91	1.14
2026-04-30	ONC	-18.77	0.91	1.14
2026-05-01	ONC	-18.77	0.91	1.14
2026-05-04	ONC	-18.77	1.06	1.14
2026-05-05	ONC	-18.77	1.06	1.14
2026-05-06	ONC	-18.77	1.06	1.14
2026-05-07	ONC	-18.77	1.06	1.14
2026-05-08	ONC	-18.77	1.06	1.13
2026-05-11	ONC	-18.73	1.17	1.13
2026-05-12	ONC	-18.73	1.17	1.09
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

1.96

Avg. EPS Est. Current Quarter

1.55

Avg. EPS Est. Next Quarter

1.67

Insider Transactions

-18.73

Institutional Transactions

1.17

Beta

0.51

Average Sales Estimate Current Quarter

1594

Average Sales Estimate Next Quarter

1670

Fair Value

285.58

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

26.2

Max Drawdown 5-Year %

-70

Target Price

413.14

P/E

70.31

Forward P/E

32.72

PEG

0.47

P/S

5.6

P/B

7.35

P/Free Cash Flow

28.84

EPS

4.48

Average EPS Est. Cur. Y

6.12

EPS Next Y. (Est.)

9.03

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

8.94

Relative Volume

1.12

Return on Equity vs Sector %

-16.1

Return on Equity vs Industry %

-0.6

EPS 1 7Days Diff

0.4

EPS 1 30Days Diff

0.62

EBIT Estimation

74.7

◆ ONC Healthcare

$315.07

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

6/20

Pullback

8/25

Volume

4/15

Valuation

13/20

TP/AR

3/10

Options

1/10

RSI

57.5

Range 1M

64.3%

Sup Dist

2.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

5/25

Growth

29/30

Estimates

7/20

Inst/Vol

6/15

Options

3/10

EPS Yr

148%

EPS NY

47.6%

52W%

57.6%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟡 HOLD +3.6% upside

Quality

14/30

Valuation

5/30

Growth

22/25

Stability

6/10

LT Trend

1/5

Upside

+3.6%

Quality

MoS

-9%

BeOne Medicines Ltd.

Sector: Healthcare

Industry: Biotechnology

Employees: 12000

BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company's commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton's Tyrosine Kinase (BTK) for the treatment of various blood cancers; TEVIMBRA, an anti-PD-1 antibody immunotherapy for the treatment of various solid tumor and blood cancers; SYLVANT for the treatment of adult patients with multicentric castleman disease; BAITUOWEI for patients with BC in premenopausal and perimenopausal women, and cancer; and PARTRUVIX for the treatment of various solid tumors. Its clinical stage products comprise Sonrotoclax BGB-11417, a small molecule Bcl-2 inhibitor; BGB-16673, a BTK targeting chimeric degradation activation compound active against wild type and mutant BTK; BG-60366, an EGFR-targeted CDAC; BG-89894 (SYH2039), a MAT2A Inhibitor; BGB-58067, an MTA-Cooperative PRMT5 Inhibitor; BG-T187 and BG-C0902, an anti-EGFRxMET trispecific antibody; BGB-26808, a HPK-1 Inhibitor; BGB-C354, an anti-B7H3 ADC; Zanidatamab, a bispecific HER2-targeted antibody; BG-C137, an anti-FGFR2b ADC; BGB-53038, a Pan-KRAS Inhibitor; BGB-B2033, an anti-GPC3x4-1BB bispecific antibody; BGB-B3227, an anti-MUC1xCD16A bispecific antibody; BG-C477, an anti-CEAADC; BGB-43395, a CDK4 Inhibitor; BG-68501, a CDK2 Inhibitor; BG-C9074, an anti-B7H4 ADC; BGB-21447, a Bcl-2 Inhibitor; and BGB-45035, an IRAK4-targeted CDAC. It also has various preclinical programs. The company has agreements Amgen, BMS, Bio-Thera, EUSA Pharma, Luye Pharmaceutical, and Novartis. The company was formerly known as BeiGene, Ltd. and changed its name to BeOne Medicines AG in May 2025. BeOne Medicines AG was founded in 2010 and is based in Basel, Switzerland.

ONC

Latest News

—

Caricamento notizie per ONC…

stock quote shares ONC – BeOne Medicines Ltd ADR Stock Price stock today

news today ONC – BeOne Medicines Ltd ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch ONC – BeOne Medicines Ltd ADR yahoo finance google finance

stock history ONC – BeOne Medicines Ltd ADR invest stock market

stock prices ONC premarket after hours

ticker ONC fair value insiders trading

AMRZ – Amrize Ltd

AMRZ — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

1.43

Margin Of Safety %

Put/Call OI Ratio

0.66

EPS Next Q Diff

1.35

EPS Last/This Y

0.54

EPS This/Next Y

0.45

Price

52.34

Target Price

65.12

Analyst Recom

1.88

Performance Q

-12.13

Upside

-12.2%

Beta

Ticker: AMRZ

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-13	AMRZ	59.24	0.61	0.12	29630
2026-04-14	AMRZ	59.96	0.60	0.30	30003
2026-04-15	AMRZ	58.74	0.60	0.83	29993
2026-04-16	AMRZ	57.17	0.61	0.13	30016
2026-04-17	AMRZ	57.71	0.60	0.18	30394
2026-04-20	AMRZ	58.22	0.57	0.11	19313
2026-04-21	AMRZ	57.12	0.56	0.26	19638
2026-04-22	AMRZ	56.59	0.56	0.33	19741
2026-04-23	AMRZ	56.85	0.56	0.28	19824
2026-04-24	AMRZ	57.56	0.55	8.25	20178
2026-04-27	AMRZ	58.16	0.57	12.95	20508
2026-04-28	AMRZ	57.51	0.59	0.58	20763
2026-04-29	AMRZ	56.78	0.60	10.22	20732
2026-04-30	AMRZ	53.79	0.72	1.35	22585
2026-05-01	AMRZ	53.38	0.75	1.27	23047
2026-05-04	AMRZ	50.91	0.76	1.36	22909
2026-05-05	AMRZ	52.64	0.77	10.62	23184
2026-05-06	AMRZ	54.91	0.64	0.72	21640
2026-05-07	AMRZ	53.46	0.65	0.86	21675
2026-05-08	AMRZ	52.87	0.64	2.91	21712
2026-05-11	AMRZ	52.05	0.65	0.35	21820
2026-05-12	AMRZ	52.33	0.66	0.87	21884
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-13	AMRZ	59.25	-	442.0	2.69
2026-04-14	AMRZ	59.95	-	471.0	2.69
2026-04-15	AMRZ	58.74	-	350.9	2.69
2026-04-16	AMRZ	57.17	-	323.7	2.69
2026-04-17	AMRZ	57.69	-	381.7	2.69
2026-04-20	AMRZ	58.19	-	366.8	2.69
2026-04-21	AMRZ	57.10	-	385.7	2.69
2026-04-22	AMRZ	56.57	-	366.9	2.69
2026-04-23	AMRZ	56.87	-	390.0	2.69
2026-04-24	AMRZ	57.58	-	417.5	2.69
2026-04-27	AMRZ	58.16	-	434.4	2.69
2026-04-28	AMRZ	57.49	-	385.9	2.69
2026-04-29	AMRZ	56.78	-	369.7	2.69
2026-04-30	AMRZ	53.80	-	188.7	2.69
2026-05-01	AMRZ	53.38	-	282.0	2.69
2026-05-04	AMRZ	50.91	-	193.9	2.69
2026-05-05	AMRZ	53.36	1.4	378.8	2.70
2026-05-06	AMRZ	54.95	1.4	344.0	2.70
2026-05-07	AMRZ	53.45	2.1	325.3	2.68
2026-05-08	AMRZ	52.87	2.1	318.7	2.68
2026-05-11	AMRZ	52.04	2.1	423.2	2.68
2026-05-12	AMRZ	52.34	2.1	446.9	2.68
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-13	AMRZ	0.33	2.58	1.21
2026-04-14	AMRZ	0.33	2.58	1.21
2026-04-15	AMRZ	0.33	2.58	1.21
2026-04-17	AMRZ	0.33	2.58	1.21
2026-04-20	AMRZ	0.33	2.49	1.21
2026-04-21	AMRZ	0.33	2.49	1.21
2026-04-22	AMRZ	0.33	2.49	1.21
2026-04-23	AMRZ	0.33	2.49	1.21
2026-04-24	AMRZ	0.33	2.49	1.21
2026-04-27	AMRZ	0.33	2.77	1.38
2026-04-28	AMRZ	0.33	2.77	1.38
2026-04-29	AMRZ	0.33	2.77	1.38
2026-04-30	AMRZ	0.33	2.77	1.38
2026-05-01	AMRZ	0.15	2.77	1.38
2026-05-04	AMRZ	0.15	3.37	1.38
2026-05-05	AMRZ	0.14	3.37	1.38
2026-05-06	AMRZ	0.14	3.37	1.38
2026-05-07	AMRZ	0.13	3.37	1.38
2026-05-08	AMRZ	0.13	3.37	1.38
2026-05-11	AMRZ	0.13	2.78	1.38
2026-05-12	AMRZ	0.13	2.78	1.43
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.16

Avg. EPS Est. Current Quarter

1.05

Avg. EPS Est. Next Quarter

1.19

Insider Transactions

0.13

Institutional Transactions

2.78

Beta

Average Sales Estimate Current Quarter

3352

Average Sales Estimate Next Quarter

3830

Fair Value

59.4

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

20.6

Max Drawdown 5-Year %

Target Price

65.12

P/E

25.04

Forward P/E

16.46

PEG

0.84

P/S

2.43

P/B

2.21

P/Free Cash Flow

21.93

EPS

2.09

Average EPS Est. Cur. Y

2.68

EPS Next Y. (Est.)

3.13

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

9.7

Relative Volume

0.89

Return on Equity vs Sector %

-7.3

Return on Equity vs Industry %

-15.7

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

446.9

◆ AMRZ Basic Materials

$52.34

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

10/20

Pullback

20/25

Volume

4/15

Valuation

14/20

TP/AR

1/10

Options

4/10

RSI

41.4

Range 1M

18.1%

Sup Dist

1.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

4/25

Growth

14/30

Estimates

2/20

Inst/Vol

4/15

Options

5/10

EPS Yr

30.1%

EPS NY

14.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +24.7% upside

Quality

7/30

Valuation

11/30

Growth

11/25

Stability

5/10

LT Trend

3/5

Upside

+24.7%

Quality

MoS

13%

Amrize Ltd

Sector: Basic Materials

Industry: Building Materials

Employees: 19000

Amrize AG engages in the provision of various building solutions for infrastructure, commercial, and residential construction markets in North America. It operates through two segments, Building Materials and Building Envelope. The Building Materials segment offers cement and aggregates, as well as ready-mix concrete, asphalt, and other construction materials. The Building Envelope segment provides advanced roofing and wall systems, including single-ply membranes, insulation, shingles, sheathing, waterproofing, and protective coatings; and adhesives, tapes, and sealants. The company was formerly known as Holcim North America Finance Ltd and changed its name to Amrize AG in December 2013. Amrize AG was incorporated in 2023 and is based in Zug, Switzerland.

AMRZ

Latest News

—

Caricamento notizie per AMRZ…

stock quote shares AMRZ – Amrize Ltd Stock Price stock today

news today AMRZ – Amrize Ltd stock forecast ,stock prediction 2023 2024 2025

marketwatch AMRZ – Amrize Ltd yahoo finance google finance

stock history AMRZ – Amrize Ltd invest stock market

stock prices AMRZ premarket after hours

ticker AMRZ fair value insiders trading

ADCT – Adc Therapeutics SA

ADCT — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

5.84

Margin Of Safety %

Put/Call OI Ratio

0.09

EPS Next Q Diff

-0.01

EPS Last/This Y

0.27

EPS This/Next Y

0.23

Price

3.44

Target Price

8.2

Analyst Recom

Performance Q

-11.92

Upside

-1,171.4%

Beta

1.82

Ticker: ADCT

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-13	ADCT	3.81	0.04	0.02	3126
2026-04-14	ADCT	3.85	0.04	0.00	3177
2026-04-15	ADCT	4.37	0.04	0.30	3243
2026-04-20	ADCT	4.26	0.03	0.61	2719
2026-04-23	ADCT	3.97	0.05	0.00	2819
2026-04-24	ADCT	3.94	0.04	0.00	2942
2026-04-27	ADCT	3.77	0.04	0.00	2953
2026-04-28	ADCT	3.78	0.04	0.00	2968
2026-04-29	ADCT	3.79	0.04	0.00	2968
2026-04-30	ADCT	3.78	0.04	124.00	3039
2026-05-01	ADCT	3.83	0.08	0.19	3162
2026-05-04	ADCT	3.67	0.09	0.11	3226
2026-05-05	ADCT	3.76	0.09	0.08	3234
2026-05-06	ADCT	3.86	0.09	0.00	3297
2026-05-07	ADCT	3.76	0.09	0.00	3296
2026-05-08	ADCT	3.5	0.09	0.36	3298
2026-05-11	ADCT	3.47	0.09	0.05	3318
2026-05-12	ADCT	3.43	0.09	0.01	3331
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-13	ADCT	3.82	-	-	-0.80
2026-04-14	ADCT	3.85	-	-	-0.80
2026-04-15	ADCT	4.36	-	-	-0.80
2026-04-16	ADCT	4.39	-	-	-0.80
2026-04-17	ADCT	4.29	-	-	-0.80
2026-04-20	ADCT	4.25	-	-	-0.80
2026-04-21	ADCT	4.09	-	-	-0.80
2026-04-22	ADCT	4.10	-	-	-0.80
2026-04-23	ADCT	3.97	-	-	-0.80
2026-04-24	ADCT	3.95	-	-	-0.80
2026-04-27	ADCT	3.76	-	-	-0.80
2026-04-28	ADCT	3.78	-	-	-0.80
2026-04-30	ADCT	3.78	-	-	-0.80
2026-05-01	ADCT	3.83	-	-	-0.80
2026-05-04	ADCT	3.67	-	-	-0.80
2026-05-05	ADCT	3.76	-	-	-0.80
2026-05-06	ADCT	3.86	-	-	-0.80
2026-05-07	ADCT	3.76	-	-	-0.86
2026-05-08	ADCT	3.50	-	-	-0.86
2026-05-11	ADCT	3.48	-	-	-0.85
2026-05-12	ADCT	3.44	-	-	-0.85
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-13	ADCT	-14.62	3.60	5.29
2026-04-14	ADCT	-14.62	3.60	5.29
2026-04-15	ADCT	-14.63	3.60	5.29
2026-04-16	ADCT	-14.63	3.60	5.29
2026-04-17	ADCT	-14.63	3.60	5.29
2026-04-20	ADCT	-14.63	3.57	5.29
2026-04-21	ADCT	-14.63	3.57	5.29
2026-04-22	ADCT	-14.63	3.57	5.29
2026-04-23	ADCT	-14.61	3.57	5.23
2026-04-24	ADCT	-14.93	3.57	5.23
2026-04-27	ADCT	-14.93	3.60	5.49
2026-04-28	ADCT	-14.93	3.60	5.49
2026-04-29	ADCT	-14.93	3.60	5.49
2026-04-30	ADCT	-14.93	3.60	5.49
2026-05-01	ADCT	-14.93	3.60	5.49
2026-05-04	ADCT	-14.93	3.24	5.49
2026-05-05	ADCT	-14.93	3.24	5.49
2026-05-06	ADCT	-14.93	3.24	5.49
2026-05-07	ADCT	-14.93	3.24	5.49
2026-05-08	ADCT	-14.93	3.24	5.49
2026-05-11	ADCT	-14.93	3.23	5.49
2026-05-12	ADCT	-14.93	3.23	5.84
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.21

Avg. EPS Est. Current Quarter

-0.21

Avg. EPS Est. Next Quarter

-0.22

Insider Transactions

-14.93

Institutional Transactions

3.23

Beta

1.82

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

89.3

Max Drawdown 5-Year %

-98.5

Target Price

8.2

P/E

Forward P/E

PEG

P/S

5.52

P/B

P/Free Cash Flow

EPS

-1.05

Average EPS Est. Cur. Y

-0.85

EPS Next Y. (Est.)

-0.62

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-173.02

Relative Volume

1.19

Return on Equity vs Sector %

36.5

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.05

EBIT Estimation

◆ ADCT Healthcare

$3.43

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

21/25

Volume

4/15

Valuation

10/20

TP/AR

2/10

Options

7/10

RSI

34.2

Range 1M

4.5%

Sup Dist

1.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

15/25

Growth

18/30

Estimates

2/20

Inst/Vol

7/15

Options

10/10

EPS Yr

24.1%

EPS NY

27.3%

52W%

58.3%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +139.1% upside

Quality

7/30

Valuation

16/30

Growth

14/25

Stability

7/10

LT Trend

3/5

Upside

+139.1%

Quality

ADC Therapeutics SA

Sector: Healthcare

Industry: Biotechnology

Employees: 188

ADC Therapeutics SA provides antibody drug conjugate (ADC) technology platform in Switzerland and the United States. Its flagship product includes ZYNLONTA, a CD19-directed ADC, received accelerated approval from the U.S. Food and Drug Administration, conditional approval from the European Commission, and conditional approval from the China National Medical Products Administration for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapy. The company is also seeking to continue expanding ZYNLONTA into international markets and into earlier lines of DLBCL and indolent lymphomas, including follicular lymphoma (FL) and marginal zone lymphoma (MZL) as a single agent and in combination through its LOTIS-5 confirmatory Phase 3 clinical trial and LOTIS-7 Phase 1b clinical trial, as well as through investigator-initiated trials (IITs). In addition, it is investigating a CD-22 targeted compound' and ADCT-602 that is in a Phase 1/2 IIT in refractory B-cell acute lymphoblastic leukemia. Further, the company's pre-clinical stage pipeline includes a portfolio of next generation investigational ADCs targeting Claudin-6, NaPi2b, PSMA, NaPi2b, and ASCT2. ADC Therapeutics SA was incorporated in 2011 and is headquartered in Epalinges, Switzerland.

ADCT

Latest News

—

Caricamento notizie per ADCT…

stock quote shares ADCT – Adc Therapeutics SA Stock Price stock today

news today ADCT – Adc Therapeutics SA stock forecast ,stock prediction 2023 2024 2025

marketwatch ADCT – Adc Therapeutics SA yahoo finance google finance

stock history ADCT – Adc Therapeutics SA invest stock market

stock prices ADCT premarket after hours

ticker ADCT fair value insiders trading

CS – Credit Suisse Group AG

UBS – UBS Group AG

UBS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.21

Margin Of Safety %

Put/Call OI Ratio

1.42

EPS Next Q Diff

0.01

EPS Last/This Y

0.49

EPS This/Next Y

1.07

Price

45.15

Target Price

48.88

Analyst Recom

2.55

Performance Q

4.24

Upside

116.3%

Beta

1.19

Ticker: UBS

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-13	UBS	42.63	1.12	0.01	129480
2026-04-14	UBS	42.88	1.06	0.27	132614
2026-04-15	UBS	43.12	1.05	0.31	132847
2026-04-16	UBS	42.72	1.05	0.77	133588
2026-04-17	UBS	43.72	1.06	0.45	135423
2026-04-20	UBS	43.83	1.14	0.66	119284
2026-04-21	UBS	43.24	1.15	0.03	119672
2026-04-22	UBS	42.41	1.45	0.06	109154
2026-04-23	UBS	41.06	1.45	0.44	108286
2026-04-24	UBS	41.41	1.43	0.21	106510
2026-04-27	UBS	42.17	1.56	0.83	104196
2026-04-28	UBS	42.1	1.55	0.33	104537
2026-04-29	UBS	42.73	1.54	0.69	104716
2026-04-30	UBS	43.92	1.52	0.28	105766
2026-05-01	UBS	43.69	1.45	1.80	107489
2026-05-04	UBS	43.39	1.45	3.10	107436
2026-05-05	UBS	44.1	1.44	0.96	107400
2026-05-06	UBS	45.2	1.44	0.35	108001
2026-05-07	UBS	44.42	1.43	0.58	108355
2026-05-08	UBS	45.2	1.43	0.49	108787
2026-05-11	UBS	44.85	1.42	1.65	109211
2026-05-12	UBS	45.14	1.42	1.38	109226
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-13	UBS	42.63	40.1	-	3.08
2026-04-14	UBS	42.89	38.4	-	3.08
2026-04-15	UBS	43.12	38.4	-	3.08
2026-04-16	UBS	42.72	38.4	-	3.08
2026-04-17	UBS	43.72	38.4	-	3.08
2026-04-20	UBS	43.83	38.4	-	3.08
2026-04-21	UBS	43.24	38.4	-	3.08
2026-04-22	UBS	42.41	38.4	-	3.08
2026-04-23	UBS	41.06	38.4	-	3.08
2026-04-24	UBS	41.42	38.4	-	3.08
2026-04-27	UBS	42.19	38.6	-	3.10
2026-04-28	UBS	42.09	38.6	-	3.10
2026-04-30	UBS	43.90	38.6	-	3.10
2026-05-01	UBS	43.68	13.6	-	2.75
2026-05-04	UBS	43.39	13.6	-	2.75
2026-05-05	UBS	44.10	13.6	-	2.96
2026-05-06	UBS	45.21	13.6	-	2.96
2026-05-07	UBS	44.40	13.6	-	2.96
2026-05-08	UBS	45.21	13.6	-	2.96
2026-05-11	UBS	44.86	13.6	-	2.96
2026-05-12	UBS	45.15	13.6	-	2.96
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-14	UBS	0.00	-4.30	0.24
2026-04-15	UBS	0.00	-4.30	0.24
2026-04-16	UBS	0.00	-4.30	0.24
2026-04-17	UBS	0.00	-4.30	0.24
2026-04-20	UBS	0.00	-4.30	0.24
2026-04-21	UBS	0.00	-4.30	0.24
2026-04-22	UBS	0.00	-4.30	0.24
2026-04-23	UBS	0.00	-4.30	0.24
2026-04-24	UBS	0.00	-4.30	0.24
2026-04-27	UBS	0.00	-5.36	0.17
2026-04-28	UBS	0.00	-5.36	0.17
2026-04-29	UBS	0.00	-5.36	0.17
2026-04-30	UBS	0.00	-5.36	0.17
2026-05-01	UBS	0.00	-5.36	0.17
2026-05-04	UBS	0.00	-5.63	0.17
2026-05-05	UBS	0.00	-5.63	0.17
2026-05-06	UBS	0.00	-5.63	0.17
2026-05-07	UBS	0.00	-5.63	0.18
2026-05-08	UBS	0.00	-5.63	0.18
2026-05-11	UBS	0.00	-5.80	0.18
2026-05-12	UBS	0.00	-5.80	0.21
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.94

Avg. EPS Est. Current Quarter

0.93

Avg. EPS Est. Next Quarter

0.95

Insider Transactions

Institutional Transactions

-5.8

Beta

1.19

Average Sales Estimate Current Quarter

10378

Average Sales Estimate Next Quarter

10236

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

8.5

Max Drawdown 5-Year %

-32.5

Target Price

48.88

P/E

16.18

Forward P/E

11.21

PEG

0.6

P/S

1.72

P/B

1.52

P/Free Cash Flow

EPS

2.79

Average EPS Est. Cur. Y

2.96

EPS Next Y. (Est.)

4.02

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

11.44

Relative Volume

0.68

Return on Equity vs Sector %

-1.9

Return on Equity vs Industry %

-1.1

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.2

EBIT Estimation

◆ UBS Financial

$45.15

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

12/20

Pullback

8/25

Volume

9/15

Valuation

6/20

TP/AR

2/10

Options

2/10

RSI

65.4

Range 1M

88.5%

Sup Dist

1.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

9/25

Growth

16/30

Estimates

4/20

Inst/Vol

2/15

Options

3/10

EPS Yr

22.3%

EPS NY

19.7%

52W%

77%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +153.5% upside

Quality

4/30

Valuation

19/30

Growth

16/25

Stability

1/10

LT Trend

4/5

Upside

+153.5%

Quality

UBS Group AG Registered

Sector: Financial Services

Industry: Banks - Diversified

Employees: 101594

UBS Group AG operates as a wealth manager and bank worldwide. It operates through five segments: Global Wealth Management, Personal & Corporate Banking, Asset Management, Investment Bank, and Non-Core and Legacy. The Global Wealth Management segment offers financial services, advice, and solutions; investment management, estate planning, and corporate advice services; and wealth management and banking products and services to private wealth and institutional customers. Its Personal & Corporate Banking segment provides banking, retirement, financing, investments, and strategic transactions to private, corporate, and institutional customers through its branch network and digital channels in Switzerland. The Asset Management segment offers diversified asset management services. Its Investment Bank segment provides equities, foreign exchange, precious metals, research, advisory, and capital markets services to institutional, corporate, financial sponsor, and Global Wealth Management customers, as well as focused rates and credit platform. The company also offers lending products, such as securities-based lending, mortgages, structured products, and tailored solutions; collateralized lending residential and commercial real estate, primarily against securities, residential and commercial real estate, other real assets (such as ships and aircraft), private market and hedge fund interest; and unsecured lending. The company was formerly known as UBS AG and changed its name to UBS Group AG in December 2014. UBS Group AG was founded in 1862 and is headquartered in Zurich, Switzerland.

UBS

Latest News

—

Caricamento notizie per UBS…

stock quote shares UBS – UBS Group AG Stock Price stock today

news today UBS – UBS Group AG stock forecast ,stock prediction 2023 2024 2025

marketwatch UBS – UBS Group AG yahoo finance google finance

stock history UBS – UBS Group AG invest stock market

stock prices UBS premarket after hours

ticker UBS fair value insiders trading

STM – STMicroelectronics N.V.

STM — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

1.23

Margin Of Safety %

Put/Call OI Ratio

0.52

EPS Next Q Diff

0.27

EPS Last/This Y

0.89

EPS This/Next Y

1.15

Price

57.95

Target Price

57.33

Analyst Recom

2.07

Performance Q

73.27

Upside

-90.9%

Beta

1.9

Ticker: STM

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-13	STM	40.34	0.60	0.06	207954
2026-04-14	STM	40.9	0.52	0.10	230968
2026-04-15	STM	40.66	0.51	0.45	238555
2026-04-16	STM	41.58	0.52	0.36	240089
2026-04-17	STM	44.22	0.52	0.25	242249
2026-04-20	STM	44.46	0.54	0.27	207306
2026-04-21	STM	44.37	0.54	0.03	213003
2026-04-22	STM	45.09	0.50	0.44	225662
2026-04-23	STM	49.71	0.52	0.18	239815
2026-04-24	STM	50.48	0.57	0.41	241502
2026-04-27	STM	50.57	0.58	0.20	247432
2026-04-28	STM	49.81	0.55	0.11	262361
2026-04-29	STM	52.7	0.57	0.40	261967
2026-04-30	STM	55.15	0.59	0.11	272943
2026-05-01	STM	55.76	0.57	0.15	283222
2026-05-04	STM	55.12	0.55	0.26	293988
2026-05-05	STM	57.31	0.55	0.14	305486
2026-05-06	STM	57.94	0.52	0.17	318057
2026-05-07	STM	55.84	0.53	0.27	320599
2026-05-08	STM	59.16	0.53	0.20	325035
2026-05-11	STM	60.1	0.51	0.35	336556
2026-05-12	STM	57.93	0.52	0.12	339936
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-13	STM	40.33	154.4	393.3	1.16
2026-04-14	STM	40.91	154.4	404.7	1.16
2026-04-15	STM	40.66	154.4	367.0	1.16
2026-04-16	STM	41.60	154.4	395.1	1.16
2026-04-17	STM	44.22	154.4	437.0	1.16
2026-04-20	STM	44.47	154.4	385.9	1.16
2026-04-21	STM	44.30	154.4	384.1	1.16
2026-04-22	STM	44.86	154.4	383.9	1.16
2026-04-23	STM	49.73	154.4	488.8	1.15
2026-04-24	STM	50.48	154.4	155.3	1.15
2026-04-27	STM	50.57	326.5	513.0	1.18
2026-04-28	STM	49.81	299.1	519.9	1.09
2026-04-30	STM	55.15	312.6	578.0	1.11
2026-05-01	STM	55.77	312.6	557.0	1.11
2026-05-04	STM	55.12	312.6	543.1	1.11
2026-05-05	STM	57.19	312.6	555.4	1.11
2026-05-06	STM	57.96	312.6	527.9	1.11
2026-05-07	STM	55.90	312.6	616.4	1.08
2026-05-08	STM	59.14	312.6	682.6	1.08
2026-05-11	STM	60.13	312.6	685.0	1.08
2026-05-12	STM	57.95	312.6	611.3	1.08
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-14	STM	0	8.10	1.27
2026-04-15	STM	0	8.10	1.27
2026-04-16	STM	0	8.10	1.27
2026-04-17	STM	0	8.10	1.27
2026-04-20	STM	0	0.76	1.27
2026-04-21	STM	0	0.76	1.27
2026-04-22	STM	0	0.76	1.27
2026-04-23	STM	0	0.76	1.27
2026-04-24	STM	0	0.76	1.27
2026-04-27	STM	0	-0.12	0
2026-04-28	STM	0	-0.12	1.25
2026-04-29	STM	0	-0.12	1.25
2026-04-30	STM	0	-0.12	1.25
2026-05-01	STM	0	-0.12	1.25
2026-05-04	STM	0	2.04	1.25
2026-05-05	STM	0	2.04	1.25
2026-05-06	STM	0	2.04	1.25
2026-05-07	STM	0	2.04	1.25
2026-05-08	STM	0	2.04	1.25
2026-05-11	STM	0	2.16	1.25
2026-05-12	STM	0	2.16	1.23
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.13

Avg. EPS Est. Current Quarter

0.25

Avg. EPS Est. Next Quarter

0.4

Insider Transactions

Institutional Transactions

2.16

Beta

1.9

Average Sales Estimate Current Quarter

3451

Average Sales Estimate Next Quarter

3725

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

3.7

Max Drawdown 5-Year %

-66.7

Target Price

57.33

P/E

376.72

Forward P/E

25.26

PEG

0.3

P/S

4.15

P/B

2.9

P/Free Cash Flow

320.65

EPS

0.15

Average EPS Est. Cur. Y

1.08

EPS Next Y. (Est.)

2.23

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

1.17

Relative Volume

1.09

Return on Equity vs Sector %

-50.9

Return on Equity vs Industry %

-52.7

EPS 1 7Days Diff

1.1

EPS 1 30Days Diff

1.08

EBIT Estimation

611.3

◆ STM Technology

$57.94

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

2/20

Pullback

0/25

Volume

4/15

Valuation

5/20

TP/AR

5/10

Options

4/10

RSI

72.9

Range 1M

86.5%

🚀

Momentum Growth

Ride accelerating trends

WATCH

Momentum

13/25

Growth

20/30

Estimates

8/20

Inst/Vol

9/15

Options

6/10

EPS Yr

124.8%

EPS NY

92.5%

52W%

92.8%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +24.5% upside

Quality

5/30

Valuation

11/30

Growth

17/25

Stability

6/10

LT Trend

1/5

Upside

+24.5%

Quality

STMicroelectronics N.V.

Sector: Technology

Industry: Semiconductors

Employees: 48000

STMicroelectronics N.V., together with its subsidiaries, designs, develops, manufactures, and sells semiconductor products in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company operates through Analog products, MEMS and Sensors Group (AM&S); Power and Discrete products (P&D); Embedded Processing (EMP); and RF Products (D&RF) segments. It offers industrial application-specific integrated circuits (ASICs) and application-specific standard products (ASSPs); power management solutions; custom analog ICs, wireless charging solutions; galvanic isolated gate and LED drivers; converters, transistors, intelligent power switches, clocks and timers, comparators, and current-sense amplifiers; micro-electro-mechanical systems (MEMS) sensors, including accelerometers, gyroscopes, magnetic sensors, pressure, temperature, presence detection, biosensors, machine learning, and edge AI processing smart sensors, as well as thermal and piezoelectric actuators; and optical sensing solutions. The company also provides silicon MOSFETs, SiC MOSFETs, IGBTs, thyristors, rectifiers, and power modules and bipolar transistors; microcontrollers, and automotive microcontrollers and secured; radio frequency (RF) communications and ASICs; car infotainment products; ultra-wide band and radar systems; and Connected Security Products; and automotive driver assistance systems. It serves automotive, industrial, personal electronics and communications equipment, and computers and peripherals markets. STMicroelectronics N.V. was incorporated in 1987 and is headquartered in Schiphol, the Netherlands.

STM

Latest News

—

Caricamento notizie per STM…

stock quote shares STM – STMicroelectronics N.V. Stock Price stock today

news today STM – STMicroelectronics N.V. stock forecast ,stock prediction 2023 2024 2025

marketwatch STM – STMicroelectronics N.V. yahoo finance google finance

stock history STM – STMicroelectronics N.V. invest stock market

stock prices STM premarket after hours

ticker STM fair value insiders trading

No more stocks to show

ONC – BeOne Medicines Ltd ADR

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ONC

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

AMRZ – Amrize Ltd

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: AMRZ

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y